GlycoEra AG is advancing glycoengineered therapeutics to address unmet medical needs. Despite significant advancements in understanding the role of glycans in human health and diseases, this knowledge has not translated well into therapeutic drug development, a consequence of the limitations and complexities of controlling glycosylation processes. GlycoEra’s platform has overcome these challenges. The CustomGlycan Platform enables glycan-mediated modes of action through the engineering of highly defined specific glycan structures, accessing a novel combinatorial dimension for the treatment of very challenging diseases.

Biotechnology

GlycoEra

Dominique Sirena

Amir Faridmoayer

Tanmoy Ganguly

Greg Fralish

The Directors Team at GlycoEra AG is responsible for providing strategic leadership and overseeing key functions across the company to ensure the successful advancement of glycoengineered therapeutics. This includes the Director of Biology and the Sr Director of Translational Research, who guide scientific and translational efforts to optimize the CustomGlycan Platform for addressing unmet medical needs. Collectively, the team drives the company's mission by aligning research, development, and operational initiatives towards pioneering novel treatments for challenging diseases.

Directors Team

About

Team members

Other teams at GlycoEra

Research and Science

Leadership Team